About Kintsugi
Kintsugi Health develops voice biomarker technology that detects signs of depression and anxiety from short speech clips. This technology helps healthcare providers screen for mental health issues more efficiently and objectively. Kintsugi primarily serves risk-bearing health systems, such as hospitals and clinics, by licensing its technology for integration into existing healthcare systems. This allows practitioners to use it as a supplementary tool for mental health screening. Kintsugi stands out from competitors by focusing on ethical AI development, ensuring fairness and privacy, and has received recognition for its innovative approach. The company's goal is to make mental healthcare more accessible and equitable by providing objective screening tools that empower healthcare practitioners to better diagnose and monitor mental health conditions.